Form 4: Elevance Health Director Elizabeth E. Tallett Reports Acquisition of Deferred Stock Units

Director Elizabeth E. Tallett reports acquisition of deferred stock units in Elevance Health, Inc.

Summary

• On May 15, 2024, Elizabeth E. Tallett, a director of Elevance Health, Inc., acquired 388 deferred stock units.
• These units were accrued under the Elevance Health, Inc. Board of Directors Compensation Program.
• The deferred stock units will be payable in Company common stock upon the earlier of (a) five years from the grant date or (b) the date Tallett ceases to be a board member, unless a later date is designated.
• Following the transaction, Tallett beneficially owns 10,291 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a transaction related to director compensation, indicating a neutral sentiment.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence due to the director's increased stake in the company.

Key Dates